XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Jan. 27, 2024
Jan. 28, 2023
Cash flows from operating activities    
Net income $ 84,304 $ 117,296
Adjustments to reconcile net income to cash provided by operating activities    
(Gain)/loss on disposal and impairment of assets (15) 6,161
(Gain)/loss on sale of investments (1,169) 155
Provision for doubtful accounts (267) 945
Depreciation and amortization 36,493 29,357
Amortization of right-of-use lease assets 56,660 57,548
Lease impairment/(settlement) (1,175) 1,347
Equity-based compensation expense 11,048 8,456
Change in deferred taxes 1,911 (2,629)
Change in receivables 4,277 42,474
Change in inventories 5,968 4,560
Change in other assets (6,314) 16,478
Change in payables (15,420) (10,624)
Change in lease liabilities (57,385) (58,651)
Change in other liabilities (13,562) (85,821)
Net cash provided by operating activities 105,354 127,052
Cash flows from investing activities    
Proceeds from disposals of assets 4,836 121
Capital expenditures (38,034) (57,439)
Purchases of investments (17,869) (6,970)
Proceeds from sales of investments 23,337 18,178
Acquisitions (26,299) (11,855)
Net cash used for investing activities (54,029) (57,965)
Cash flows from financing activities    
Payments on debt and finance lease liabilities (346) (92)
Holdback payments for acquisitions (5,000) (5,000)
Stock issued for stock and employee benefit plans, net of shares withheld for taxes 6,241 (1,771)
Repurchases of common stock (40,022) (5,004)
Dividends paid to shareholders (24,177) (22,027)
Dividends paid to minority interest joint venture partners [1] (1,172) 0
Net cash used for financing activities (64,476) (33,894)
Effect of exchange rate changes on cash and equivalents (348) (4)
Change in cash, cash equivalents and restricted cash (13,499) 35,189
Cash, cash equivalents and restricted cash at beginning of period 346,678 248,856
Cash, cash equivalents and restricted cash at end of period 333,179 284,045
Supplemental disclosure of non-cash investing activities    
Capital expenditures included in payables $ 3,008 $ 2,828
[1] Includes dividends paid to joint venture minority partners resulting from the repatriation of dividends from our foreign earnings that we no longer consider permanently reinvested